People often skip neurological meds when out-of-pocket costs rise


When out-of-pocket drug costs rise, patients with common neurological disorders are more likely to forgo their medication, a U.S. study suggests.  Private insurance claims data show patients with Alzheimer’s disease, Parkinson’s disease and peripheral neuropathy were more likely to cut back on prescription medications when out-of-pocket costs were high, researchers report in Neurology. 

Previous Article

Polypharmacy dangerous to patients with heart failure

Next Article

Adults Unintentionally Make It Easy for Young Children to Eat Dangerous Pills